GLP1R and pancreatic insulinoma: Later, Waser et al. reported that in their series of thirty-eight insulinomas, all tumours classified as ‘benign’ (n = 31) expressed GLP-1R with immunohistochemistry, while only one insulinoma classified as ‘malignant’ (n = 7) showed positivity [10].